Kartik Shah in

Kartik Shah

Evaluator · DISC type Csd
Chief Business Officer at Tactile Therapeutics, Inc.
📍 San Diego, California, United States

Kartik is the Chief Business Officer at Tactile Therapeutics, a company developing targeted protein degradation solutions for neuro-inflammation. A graduate of Harvard Business School and the University of Pennsylvania, he has a strong background in corporate development and commercial strategy within the biotechnology industry, including co-founding Oxeia Biopharmaceuticals to develop a first-in-class concussion drug.

Personally, Kartik is a passionate advocate for healthcare advancement, driven by his familys own experiences. He has publicly shared his gratitude for the healthcare professionals who cared for his wife during her battle with breast cancer, highlighting his deep personal connection to medical innovation and patient care.

He previously drove a $640 million U. S. rights deal for a former employer, Atara Biotherapeutics.

Read the full overview →
Experience
26 Years
Current Role
Chief Business Officer
Job Level
Leadership
Location
San Diego, California, United States
Personality Overview

How Kartik shows up

Quality Focused
Thorough Evaluator
Fast But Analytical

They focus on the results, but can still be quite procedural and analytical about how to get there They are not very likely to become strong advocates of your product or service They have a unique set of diverse traits where they are decisive and methodical but can sometimes be extra cautious and skeptical

Priorities

Topics Kartik cares about

Neuro-inflammation
His current company, Tactile Therapeutics, is focused on developing molecular glues to treat neuro-inflammatory conditions.
Treating Brain Injury
Co-founded Oxeia Biopharmaceuticals, which focused on developing a novel drug for concussions, and he celebrates positive clinical results in this area.
+5 more topics Login to view topics
Career

Work history

4-2024
Chief Business Officer
Tactile Therapeutics, Inc.
2014
Director & Co-founder
Oxeia Biopharmaceuticals Inc
2019 - 3-2024
Commercial Strategy
Atara Biotherapeutics
2014 - 2019
CBO, CFO & Director
Oxeia Biopharmaceuticals, Inc.
2012 - 2014
Vice President, Business Development
Cynvenio Biosystems, Inc.
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2006 - 2008
MBA
Harvard Business School
1-1998 - 5-1999
MS
University of Pennsylvania
9-1995 - 5-1999
BSE
University of Pennsylvania
Social presence
in
Behavioral profile

DISC profile (public)

C

Calculativeness (C)

Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Kartik. Free, 10 seconds.